Search Fred Hutch Extranet

ATTENTION: The NIH announced new GCP training expectations that are effective January 1, 2017. The new policy requires basic GCP training, and regular refresher GCP training every three years. The policy can be found at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-148.html.

The leadership at Fred Hutch and across the Cancer Consortium has determined that all Fred Hutch and Consortium investigators and staff involved in clinical trials, regardless of funding source, will be required to meet the new GCP training requirements as of January 1, 2017. The Fred Hutch or UW Cancer Consortium Principal Investigator of a clinical trial is responsible for ensuring that GCP training has been taken by staff supporting the clinical trial.

If you have documentation or certification that you have taken GCP training more than three years ago, you will need to take a GCP refresher course.

Summary

Good Clinical Practice (GCP) is a standard for the design, conduct, performance, monitoring, auditing, recording, analyzing and reporting of clinical trials. Compliance with GCP provides assurance that the study data are credible and accurate and that the rights, safety, confidentiality and well-being of research participants are protected.

Who needs training?

GCP training is required for all Fred Hutch investigators and clinical trial staff involved in a clinical trial, regardless of funding source.

Clinical Trial

A research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.

Investigator

The individual responsible for the conduct of the clinical trial at a trial site. If a clinical trial is conducted by a team of individuals at a trial site, the investigator is the responsible leader of the team and may be called the principal investigator.

Clinical Trial Staff

Individuals, identified by the investigator, who are responsible for study coordination, data collection and data management. The central focus of clinical trial staff is to manage participant recruitment and enrollment, to maintain consistent study implementation, data management, and to ensure integrity and compliance with regulatory and reporting requirements. These individuals may also seek informed consent from prospective participants, enroll and meet with research participants, and collect and record information from research participants. Clinical trial staff may also be called the research coordinator, study coordinator, research nurse, study nurse or sub-investigator.

If my primary affiliation is with another institution, do I need to meet the Fred Hutch GCP training requirements?

It depends on your role. If you are the principal investigator on a study submitted to the Fred Hutch IRB, or you are relying on the Fred Hutch IRB through an Individual Investigator Agreement you need to meet the Fred Hutch GCP training requirements.

Other non-Fred Hutch investigators and study staff should meet the requirements of their own institution; the PI is responsible for ensuring all study staff have met the relevant institutional requirements. For more detailed information on who needs to complete GCP training see IRB Policy 2.20 Training.

Additional GCP training requirements for investigator held IND/IDE multi-center studies:

Fred Hutch or UW Consortium "Sponsor-Investigators" who hold the Investigational New Drug (IND) or Investigational Device Exemption (IDE) for a multi-center trial may be subject to additional training requirements by the Consortium's External Performance Site Assessment Committee (EPSAC). For more information on EPSAC visit the Cancer Consortium website.

Training Options

  • Collaborative Institutional Training Initiative (CITI) online GCP training courses found at http://www.citiprogram.org/. Click here for tips and instructions for signing up for CITI courses.
    • Good Clinical Practice for Clinical Trials with Investigational Drugs and Medical Devices (U.S. FDA Focus)
    • Good Clinical Practice for Clinical Trials with Investigational Drugs and Biologics (ICH Focus)
    • GCP FDA Refresher (acceptable for refresher only)
    • GCP ICH Refresher (acceptable for refresher only)
  • GCP training offered by Institutes within the NIH, including NIAID and NIDA.
  • Any TransCelerate-approved GCP training course.
  • For social-behavioral GCP training, an NIH-developed course is available through the Society of Behavioral Medicine.
  • Other equivalent GCP training such as the Association of Clinical Research Professional's GCP classroom training course or the Barnett Education Services GCP classroom training course.┬áThe IRB will accept other GCP training if the course covered the same topics as CITI and written documentation can be provided.

Documentation

Please send documentation of your completed training to iro@fredhutch.org.

Questions?

If you have questions about the GCP training requirements, please contact iro@fredhutch.org or CRScustomerservice@fredhutch.org.